Get started
EMERGENT BIOSOLUTIONS INC COM STK USD0.001EMERGENT BIOSOLUTIONS INC COM STK USD0.001EMERGENT BIOSOLUTIONS INC COM STK USD0.001

EMERGENT BIOSOLUTIONS INC COM STK USD0.001

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

0IGA chart


Full chart

0IGA upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪609.57 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.000 USD
Net income (FY)
‪−760.50 M‬ USD
Revenue (FY)
‪1.05 B‬ USD
Shares float
‪52.75 M‬
Beta (1Y)
4.74

Employees


Employees (FY)
‪1.6 K‬
Change (1Y)
−900 −36.00%
Revenue / Employee (1Y)
‪655.81 K‬ USD
Net income / Employee (1Y)
‪−475.31 K‬ USD

About Emergent BioSolutions Inc.


Sector
Health Technology
CEO
Joseph C. Papa
Headquarters
Gaithersburg
Website
emergentbiosolutions.com
Founded
1998
FIGI
BBG00JVRNK04
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0IGA news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

0IGA highest yielding bonds


EBS5025997
Emergent BioSolutions Inc. 3.875% 15-AUG-2028
Yield to maturity
10.47%
Maturity date
Aug 15, 2028
EBS5025998
Emergent BioSolutions Inc. 3.875% 15-AUG-2028
Yield to maturity
—
Maturity date
Aug 15, 2028

Explore more bonds 

Frequently Asked Questions


The current price of 0IGA is 10.570 USD — it has decreased by −8.57% in the past 24 hours. Watch EMERGENT BIOSOLUTIONS INC COM STK USD0.001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange EMERGENT BIOSOLUTIONS INC COM STK USD0.001 stocks are traded under the ticker 0IGA.
0IGA stock has fallen by −6.26% compared to the previous week, the month change is a 1.23% rise, over the last year EMERGENT BIOSOLUTIONS INC COM STK USD0.001 has showed a 568.99% increase.
We've gathered analysts' opinions on EMERGENT BIOSOLUTIONS INC COM STK USD0.001 future price: according to them, 0IGA price has a max estimate of 16.00 USD and a min estimate of 12.00 USD. Watch 0IGA chart and read a more detailed EMERGENT BIOSOLUTIONS INC COM STK USD0.001 stock forecast: see what analysts think of EMERGENT BIOSOLUTIONS INC COM STK USD0.001 and suggest that you do with its stocks.
0IGA reached its all-time high on Feb 11, 2021 with the price of 121.120 USD, and its all-time low was 1.480 USD and was reached on Feb 6, 2024. View more price dynamics on 0IGA chart.
See other stocks reaching their highest and lowest prices.
0IGA stock is 4.51% volatile and has beta coefficient of 4.74. Track EMERGENT BIOSOLUTIONS INC COM STK USD0.001 stock price on the chart and check out the list of the most volatile stocks — is EMERGENT BIOSOLUTIONS INC COM STK USD0.001 there?
Today EMERGENT BIOSOLUTIONS INC COM STK USD0.001 has the market capitalization of ‪568.39 M‬, it has increased by 1.38% over the last week.
Yes, you can track EMERGENT BIOSOLUTIONS INC COM STK USD0.001 financials in yearly and quarterly reports right on TradingView.
EMERGENT BIOSOLUTIONS INC COM STK USD0.001 is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
0IGA earnings for the last quarter are 1.37 USD per share, whereas the estimation was 0.10 USD resulting in a ‪1.23 K‬% surprise. The estimated earnings for the next quarter are −0.43 USD per share. See more details about EMERGENT BIOSOLUTIONS INC COM STK USD0.001 earnings.
EMERGENT BIOSOLUTIONS INC COM STK USD0.001 revenue for the last quarter amounts to ‪293.80 M‬ USD, despite the estimated figure of ‪290.33 M‬ USD. In the next quarter, revenue is expected to reach ‪249.50 M‬ USD.
0IGA net income for the last quarter is ‪114.80 M‬ USD, while the quarter before that showed ‪−283.10 M‬ USD of net income which accounts for 140.55% change. Track more EMERGENT BIOSOLUTIONS INC COM STK USD0.001 financial stats to get the full picture.
No, 0IGA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 4, 2025, the company has ‪1.60 K‬ employees. See our rating of the largest employees — is EMERGENT BIOSOLUTIONS INC COM STK USD0.001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EMERGENT BIOSOLUTIONS INC COM STK USD0.001 EBITDA is ‪25.40 M‬ USD, and current EBITDA margin is −4.09%. See more stats in EMERGENT BIOSOLUTIONS INC COM STK USD0.001 financial statements.
Like other stocks, 0IGA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EMERGENT BIOSOLUTIONS INC COM STK USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EMERGENT BIOSOLUTIONS INC COM STK USD0.001 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EMERGENT BIOSOLUTIONS INC COM STK USD0.001 stock shows the neutral signal. See more of EMERGENT BIOSOLUTIONS INC COM STK USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.